Search Results

Sublingual zolpidem tartrate lozenge for the treatment of insomnia

Author: Lankford, Alan

Source: Expert Review of Clinical Pharmacology, Volume 2, Number 4, July 2009 , pp. 333-337(5)

Publisher: Expert Reviews

Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet

Authors: de Groot, Hans; Bijl, Annemarie

Source: Allergy, Volume 64, Number 6, June 2009 , pp. 963-964(2)

Publisher: Blackwell Publishing

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment

Authors: Horak, F.; Jaeger, S.; Worm, M.; Melac, M.; Didier, A.

Source: Clinical & Experimental Allergy, Volume 39, Number 3, March 2009 , pp. 394-400(7)

Publisher: Blackwell Publishing

Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy

Authors: Didier, A.; Melac, M.; Montagut, A.; Lhéritier-Barrand, M.; Tabar, A.; Worm, M.

Source: Allergy, Volume 64, Number 1, January 2009 , pp. 166-171(6)

Publisher: Blackwell Publishing

Sublingual fentanyl tablet approved in the UK.

Source: Inpharma, Volume 1, Number 1658, 2008-10-04 , pp. 18-18(1)

Publisher: Adis International

A sublingual grass pollen allergy vaccine tablet [Oralair Grasses] has shown positive results in an allergen challenge chamber study.

Source: Inpharma, Volume 1, Number 1654, 2008-09-06 , pp. 6-6(1)

Publisher: Adis International

Stallergenes has been granted marketing authorisation for its sublingual grass pollen allergy vaccine tablet

Source: Inpharma, Volume 1, Number 1644, 2008-06-28 , pp. 18-18(1)

Publisher: Adis International

Bioequivalence Following Buccal and Sublingual Placement of Fentanyl Buccal Tablet 400 µg in Healthy Subjects

Authors: Darwish, Mona; Kirby, Mary; Jiang, John G.; Tracewell, William; Philmore Robertson Jr,

Source: Clinical Drug Investigation, Volume 28, Number 1, 2008 , pp. 1-7(7)

Publisher: Adis International

Fast-Disintegrating Sublingual Epinephrine Tablets: Effect of Tablet Dimensions on Tablet Characteristics

Authors: Rawas-Qalaji, Mutasem M.; Simons, F. Estelle R.; Simons, Keith J.

Source: Drug Development and Industrial Pharmacy, Volume 33, Number 5, May 2007 , pp. 523-530(8)

Publisher: Informa Healthcare

Aerosol delivery of ergotamine tartrate via a breath-synchronized plume-control inhaler in humans

Authors: Armer, T.A.; Shrewsbury, S.B.; Newman, S.P.; Pitcairn, G.; Ramadan, N.

Source: Current Medical Research and Opinion, Volume 23, Number 12, December 2007 , pp. 3177-3187(11)

Publisher: Informa Healthcare

Asenapine, administered as a fast-dissolving sublingual tablet, appears to be effective for the treatment of acute schizophrenia

Source: Inpharma, Volume 1, Number 1616, 2007-12-01 , pp. 6-6(1)

Publisher: Adis International

A sublingual formulation of desmopressin is preferred over an oral tablet by children and adolescents for the treatment of primary nocturnal enuresis

Source: Inpharma, Volume 1, Number 1608, 2007-10-06 , pp. 15-15(1)

Publisher: Adis International

Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children

Authors: Ibañez, Maria Dolores; Kaiser, Friedrich; Knecht, Roland; Armentia, Alicia; Schöpfer, Helmut; Tholstrup, Bente; Bufe, Albrecht

Source: Pediatric Allergy and Immunology, Volume 18, Number 6, September 2007 , pp. 516-522(7)

Publisher: Blackwell Publishing

A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis

Authors: Lottmann, H.; Froeling, F.; Alloussi, S.; El-Radhi, A. S.; Rittig, S.; Riis, A.; Persson, B.-E.

Source: International Journal of Clinical Practice, Volume 61, Number 9, September 2007 , pp. 1454-1460(7)

Publisher: Blackwell Publishing

Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage

Authors: Durham, S. R.; Riis, B.

Source: Allergy, Volume 62, Number 8, August 2007 , pp. 954-957(4)

Publisher: Blackwell Publishing

Cost-effectiveness of grass allergen tablet (GRAZAX^®) for the prevention of seasonal grass pollen induced rhinoconjunctivitis - a Northern European perspective

Authors: Bachert, C.; Vestenbæk, U.; Christensen, J.; Griffiths, U. K.; Poulsen, P. B.

Source: Clinical & Experimental Allergy, Volume 37, Number 5, May 2007 , pp. 772-779(8)

Publisher: Blackwell Publishing

Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: A double-blind, randomised study

Authors: Rak, Sabina; Yang, William; Pedersen, Martin; Durham, Stephen

Source: Quality of Life Research, Volume 16, Number 2, March 2007 , pp. 191-201(11)

Publisher: Springer

Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial

Authors: Kleine-Tebbe, J.; Ribel, M.; Herold, D. A.

Source: Allergy, Volume 61, Number 2, February 2006 , pp. 181-184(4)

Publisher: Blackwell Publishing

Effect of Excipient and Processing Variables on Adhesive Properties and Release Profile of Pentoxifylline From Mucoadhesive Tablets

Authors: Surapaneni, Madhu; Das, Sudip; Das, Nandita

Source: Drug Development and Industrial Pharmacy, Volume 32, Number 3, 2006 , pp. 377-387(11)

Publisher: Informa Healthcare

Transdermal buprenorphine in the treatment of chronic pain

Author: Sittl, Reinhard

Source: Expert Review of Neurotherapeutics, Volume 5, Number 3, May 2005 , pp. 315-323(9)

Publisher: Expert Reviews